6-mercaptopurine beats a bum rap.
暂无分享,去创建一个
[1] J. Lewis,et al. Corticosteroids and immunomodulators: postoperative infectious complication risk in inflammatory bowel disease patients. , 2003, Gastroenterology.
[2] C. Bodian,et al. The safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease: a retrospective cohort study. , 2003, Gastroenterology.
[3] J. Markowitz. Therapeutic efficacy and safety of 6-mercaptopurine and azathioprine in patients with Crohn's disease. , 2003, Reviews in gastroenterological disorders.
[4] D. Jewell,et al. Long‐term risk of malignancy after treatment of inflammatory bowel disease with azathioprine , 2002, Alimentary pharmacology & therapeutics.
[5] Dermot Kelleher,et al. Increased incidence of non-Hodgkin's lymphoma in inflammatory bowel disease patients on immunosuppressive therapy but overall risk is low , 2000, Gut.
[6] J. Schwartz,et al. Azathioprine for maintenance of remission in Crohn's disease: benefits outweigh the risk of lymphoma. , 2000, Gastroenterology.
[7] G. Fick,et al. Azathioprine for maintaining remission of Crohn's disease. , 1998, The Cochrane database of systematic reviews.
[8] W. Connell,et al. Treating Inflammatory Bowel Disease During Pregnancy , 1999, Drug safety.
[9] M. Kamm,et al. Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease , 1994, The Lancet.
[10] M. Kamm,et al. Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience. , 1993, Gut.
[11] S. Meltzer,et al. 6-Mercaptopurine in the management of inflammatory bowel disease: short- and long-term toxicity. , 1989, Annals of internal medicine.
[12] D. Present,et al. Shortcomings of the National Crohn's Disease Study: the exclusion of azathioprine without adequate trial. , 1981, Gastroenterology.
[13] R. Summers,et al. National Cooperative Crohn's Disease Study: results of drug treatment. , 1979, Gastroenterology.
[14] F. Rosner,et al. Acute leukemia and immunosupressive drug use: a review of patients undergoing immunosuppressive therapy for non-neoplastic diseases. , 1979, Archives of internal medicine.
[15] E. Swarbrick,et al. Azathioprine for Crohn's disease. , 1969, Lancet.